|Item#||Name||Size & Form||Brand||Price||Actions|
Curcumin nutrients (curcumin, demethoxycurcumin, bisdemethoxycurcumin) are usually poorly absorbed when taken by mouth. Phytosome proprietary technology solves this problem. In Curcumin Phytosome featuring Meriva® , each curcuminoid molecule is individually complexed with molecules of the vital cell membrane nutrient phosphatidylcholine (PC). By facilitating curcumins’ entry into human cells and tissues, PC gives this product superior bioactivity over non-phytosome curcumin supplements.
Phytosomes are molecular complexes formed between individual curcumin molecules and molecules of phosphatidylcholine (PC).3 Curcumin molecules normally mix very poorly into water and also are quickly destroyed by the water medium.1,3 Curcumins formed into phytosomes with PC disperse almost completely into water,1 and when taken by mouth are far better absorbed into the blood than are conventional curcumin supplements.3,4 In addition, the Phytosome technology also harnesses the additional health benefits of PC itself.
Taken daily as a dietary supplement, the curcumin-PC phytosome combination can:
• Measurably enhance the benefits of the curcumins.*
• Protect the curcumins against premature molecular breakdown.*
• Promote healthy functioning of the joints and other organs.*
• Support healthy management of C-reactive protein, a bloodborne health indicator.*
The Phytosome technology involves wrapping each curcumin molecule with one or more molecules of PC. This envelope of PC helps the bound curcumin molecule disperse in the water phase while shielding it against water damage. Researchers believe that once the phytosome supplement is swallowed, the unit phytosomes readily diffuse through the intestinal contents, facilitated by PC’s excellent miscibility with water.6,7 After a phytosome arrives at an intestinal lining cell, the PC molecule readily merges with the outer cell membrane and the curcumin molecule passes into the cell interior. Subsequently the intestinal cells release the curcumins into the circulating blood, from which they travel to the other tissues.
Another attribute of Phytosome technology is that more than being just the delivery vehicle, PC is an important substance for life.7,8 PC is a phospholipid (pronounced fos-fo-lip-id) that was one of the first “health foods,” and multiple clinical trials have documented PC’s support for liver, intestinal, lung and circulatory health.8 PC’s clinical benefits derive mainly from its central role in cell membranes, the main driving force for all cells.8,9 Once absorbed, curcumin also gets into cell membranes.10
Cell membranes are our cells’ dynamic action zones. These are the structures that generate energy in the cell and utilize this energy to support virtually all the important life processes.7-9 They are continuous, uninterrupted sheets of molecules, strong yet flexible. The membrane’s foundation or matrix is always composed mostly of PC molecules, between which are inserted most of the cell’s catalytic, “can-do” proteins in the forms of receptors, signal transducers, and various other versions of enzymes.7
PC is a universal building block for cell membranes.8 PC is essential for assembling, maintaining and repairing the membrane matrix, which in turn ensures the structural and functional competence of the entire cell membrane system. Vital to all life processes, PC has been called a Vital Lipid for Life.11 Numerous experimental and clinical studies document that PC helps preserve cell membrane systems against toxic or viral attack.8 And as curcumin enters the cell it specifically binds to the PC in the membrane.10 This is strong indication that these two nutrients complement each other’s actions to fundamentally support cell membrane competence.
The curcumins are potent cell membrane protectants. They are versatile antioxidants that help prevent “free-radical” damage from oxygen and nitrogen-centered oxidants.12,13 The curcumins inhibit free radical attack on the cell, whether on the DNA and genes, on the mitochondria that generate energy, or on the membrane system.13 Membranes are especially vulnerable to free radical attack, and the presence of curcumin helps guard them against destruction from lipid peroxidation.10,13 The curcumins’ protective capacities extend even beyond their antioxidant actions, as evidenced from their capacity to protect joint tissues against runaway destructive activity of the body’s immune system.
Studies with both rats and humans demonstrate that dietary supplementation with the curcumin-PC phytosome results in dramatically higher blood (that is, plasma) curcumin levels, as compared to other curcumins consumed in non-phytosome, conventional molecular forms.4,14,15
For the rat study, rats were fasted overnight then were force-fed equivalent amounts of curcumin either as phytosome or non-phytosome material.4 Blood samples were obtained at 0, 15, 30, 60, or 120 minutes after feeding. The phytosome preparation showed superior curcumin absorption into the plasma, beginning at 30 minutes. For the period 0-120 minutes, curcumin was absorbed some 5.6 times better from phytosomes versus non-phytosomes. Further, the liver accumulated significantly more curcumin from the Meriva® phytosome versus the non-phytosome preparation.
In human subjects, the Meriva® curcumin was about 10 times better absorbed, compared to non-phytosome curcumin.14
In a recent double blind human trial,14 Meriva® supported healthy joint function and down-regulated molecular triggers of tissue damage. The most favorable indicator of Meriva®’s benefit in this trial was treadmill performance. After 2 months on Meriva®, the average distance walked at a brisk 3 kilometers per hour, with a treadmill incline of 10 percent, was significantly improved as compared to placebo. This impressive human finding on joint support was consistent with other positive findings from controlled studies with horses and dogs.15 In these veterinary studies, the identical phytosome preparation improved joint health and lowered TNF (tumor necrosis factor), a cytokine messenger molecule known to trigger damage to the joints and other tissues.
In experiments with cultured cells, which bypass bioavailability limitations since the curcumins can be added to the culture at any desired concentration, the curcumins support processes that favor joint building while opposing those processes that favor joint breakdown.16 The curcumins also down-regulated immune system cytokine messengers linked to joint tissue breakdown, most notably TNF, IL-1B (Interleukin-1 beta) and IL-6 (Interleukin-6). At a higher level of control, the curcumins also down-regulated NF-kB (Nuclear Factor-kappa B)17 and AP-1 (Activating Protein-1),18 master regulators of the genes that code for COX-2 (cyclo-oxygenase 2), lipoxygenases and other joint-destroying enzymes.12,18,19
The key to success in the human double-blind trial was Meriva®’s measurably superior delivery of curcumins to the tissues.14 This trial also demonstrated that Meriva® could significantly down-regulate C-reactive protein (CRP), a clinically relevant indicator of whole-body health as well as joint health.
C-reactive protein is produced by the liver and released into the blood, and “highly-sensitive” blood CRP level (hs-CRP) is increasingly employed as a “biomarker” particularly for cardiovascular health.20,21 Blood hs-CRP normally is very low in healthy individuals, but predictably becomes increased when the immune system is active against tissue damage.22 Substantial clinical research indicates that low blood CRP is consistent with relatively good health and conversely, that elevated CRP is a harbinger of impaired function.20-22 In the human Meriva® trial,14 those subjects who received Meriva® had a marked lowering of their elevated CRP levels after 2 months. This was a statistically significant benefit as compared to the placebo group, which experienced no appreciable lowering of CRP.
Curcumin and its related curcumins from turmeric root have been a revered traditional cure-all for millennia.1 Modern science and clinical medicine has objectively verified a great many of these traditional folk applications. Now that the curcumins can be effectively delivered to the human tissues via Phytosome technology, their benefits observed experimentally are now available to all. For improved wellbeing and for optimal health long-term, Meriva® Phytosome Curcumins is the “gold standard” of curcumin dietary supplements.
1.Hatcher H, Planalp R, Cho J, et al. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 2008;65:1631-1652.
2.Garcea G, Berry DP, Jones DJ, et al. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev 2005:14:120-125.
3.Kidd PM. Bioavailability and activity of phytosome complexes from botanical polyphenols: The silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev 2009;14(3):226-246.
4.Marczylo TH, Verschoyle RD, Cooke DN, et al. Comparison of systemic bioavailability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol 2007;60:171-177.
5.Indena SpA. www.indena.com [Accessed February 20, 2010]
6.Bombardelli E, Curri SB, Della Loggia R, et al. Complexes between phospholipids and vegetal derivatives of biological interest. Fitoterapia 1989;60:1-9.
7.Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell (Fourth Edition). New York: Garland Science; 2002.
8.Kidd PM. Phosphatidylcholine (Monograph). In: Czap K, Miller AL, Head KA, et al, eds. Alternative Medicine Review Monographs Volume One. Dover, ID: Thorne Research, Inc.; 2002:310-315.
9.Hulbert A, Else P. Review: membranes and the setting of energy demand. J Exp Biol 2005;208:1593-1599.
10.Barry J, Fritz M, Brender, JR, et al. Determining the effects of lipophilic drugs on membrane structure. J Am Chem Soc 2009;131:4490-4498.
11.Vital Lipids Copyright © and TM Science and Ingredients, Inc., Laguna Niguel, Ca, USA, 2007.
12.Jurenka J. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research. Altern Med Rev 2009;14:141-153.
13.Soni K, Kuttan R. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. J Physiol Pharmacol 1992;36:273-275.
14.Belcaro G, Cesarone MR, Dugall M, et al. Product-evaluation registry of Meriva®, a curcumin-phosphatidylcholine complex, for the complementary management of ostroarthritis. Panminerva Med 2010; in press.
15.Gaspardo B, Colitti M, Scaini C, et al. Transcriptosome modification of peripheral white blood cells after dietary administration of curcumin in osteoarthritic affected dogs. Plant & Animal Genomes XVIII Conference San Diego, CA, USA 2010; Abstract 787. Also data on file, University of Udine, Italy, 2010.
16.Henrotin Y, Clutterbuck AL, Allaway D, et al. Review: Biological actions of curcumin on articular chondrocytes. Osteoarthritis and Cartilage 2010;18:141-149.
17.Singh S, Aggarwal B. Activation of transcription factor NF-kB is suppressed by curcumin (diferuloyl methane). J Biol Chem 1995;270:24995-25000.
18.Liacini A, Sylvester J, Li WQ, Zafarullah M. Inhibition of interleukin 1-stimulated MAP kinases, activating protein-1 (AP-1), and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates metalloproteinase gene expression in articular chondrocytes. Matrix Biol 2002;21:251-262.
19.Huang MT, Lysz T, Ferraro T, et al. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 1991;51:813-819.
20.Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010;375(9709):132-140.
21.Ray KK, Cannon CP, Cairns R, et al. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI
22. Arterioscler Throm Vasc Biol 2009;29:424-430. 22.Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. Circulation 2003;107:499-511.
*Statements on this site have not been evaluated by the Food and Drug Administration. Products on this site are not intended to diagnose, treat, cure, or prevent any disease.
Prices are subject to change at anytime and without notice. The majority of the product information has been reprinted from the manufacturer.